AmpC beta-lactamase-mediated cefpodoxime-resistant Escherichia coli isolated from faecal samples of healthy volunteers

J Antimicrob Chemother. 2006 Feb;57(2):369-71. doi: 10.1093/jac/dki438. Epub 2005 Dec 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / metabolism*
  • Cefpodoxime
  • Ceftizoxime / analogs & derivatives*
  • Ceftizoxime / pharmacology
  • Cephalosporin Resistance*
  • Escherichia coli / drug effects*
  • Escherichia coli / enzymology*
  • Feces / microbiology*
  • Humans
  • Microbial Sensitivity Tests
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Ceftizoxime
  • AmpC beta-lactamases
  • beta-Lactamases